Jeevan Scientific Technology Limited .... Hidden Gem in Clinical Pharma Space

Today I am expressing my view on Jeevan Scientific, a proxy pharma player in the field of clinical research and clinical trial.

Company

Jeevan Scientific Technology Limited, established in the year 1999, is a global management consulting, technology services and outsourcing company located in Hyderabad, India.

Jeevan has been designed with state of the art facility to provide a broad range of clinical research services for healthcare/pharmaceutical industries across the globe.

Jeevan is a perfect blend of technology, innovation and expertise, which enables it to provide reliable, cost-effective and technology driven services and solutions to the clients across the globe. Jeevan's commitment to quality, and customer-focused approach bundled with outstanding expertise distinguishes it from others. The world-class team of highly qualified and experienced workforce enables Jeevan to meet the client expectations and deliver within the timeframe. Jeevan's service portfolio enables it to provide an integrated solution for the management of clinical data right from its inception to completion.

Board of Directors

Mr. SREERAMA KOTESWARA RAO SURAPANENI, Chairman
Mr. KRISHNA KISHORE KUCHIPUDI, Executive Vice Chairman & Managing Director
Mr. RAJENDRA PRASAD MUPPAVARAPU, CEO & Executive Director
Mr. RAGHAV BEERAM, Director
Ms. VANAJA KUCHIPUDI, Director
Mr. RAVI BABU THAMMAREDDY, Director
Mr. BHANU PRAKASH GALI, Director
Mr. VIJAY KUMAR ANNAM, Director
Mr. RAMA KRISHNA PRASAD KAKARALA, Director

The Visionary Leadership

 

Jeevan come to my focus after Mr. Rajendra Prasad, formerly associated with Aurobindo Pharma joined the board of Jeevan as CEO. Mr. Rajendra Prasad, has the vision of developing Jeevan as a fully functional CRO. Prasad is an excellent strategist, and a prudent decision maker with insightful and articulate vision. Prasad has been an exemplary leader in establishing and maintaining long-term business relationships. Before joining with Jeevan, Prasad was associated with Veeda Clinical Research as Chief Business Officer.

He had been associated with Veeda since its inception in 2004, in various leadership roles and had contributed immensely in the growth of Veeda both in “Technical” and “Business” fronts. He has a diversified experience and knowledge of various functional domains in the CRO industry including clinical operations, BA/BE studies, data management and bioanalytical.

He has lead the team in research and development and has hands on experience in developing and validating various bioanalytical methods. Prasad has a rich experience of more than 20 years in pharmaceutical and CRO industry and has worked in several leading names in the industry including GVK Bio, Aurobindo Pharma, Cadila Pharma, Lambda Therapeutics, Sun Pharma and Vimta Labs. He is a well-known "team builder" in CRO industry. Prasad holds a Master´s Degree in Pharmacy.

Outlook

Promoter and HNI holding 62% stake in company, Jeevan posted 12.3 cr top line and 0.49 cr bottom line in latest 9 month ended 2016-17  ( last full year profit was 0.42 cr ). Equity capital of company is low i.e. 6 cr with market capitalization of just 32 cr. Management is working hard for creating value for investors. Maximum turnaround company comes out from pharma sector we are highly bullish in this stock. investor may consider in long term view. Stock trading only in BSE @ 38 level. Only long term investor can buy stock for multiple gain in future.

Disc: holding stock in core portfolio.

NOTE : THE ABOVE IS NOT A RESEARCH REPORT NOR A RECOMMENDATION  BUT INFORMATION AS AVAILABLE ON PUBLIC DOMAIN.

Registration status with SEBI: I am not registered with SEBI under the (Research Analyst) regulations 2014 and as per clarifications provided by SEBI: “Any person who makes recommendation or offers an opinion concerning securities or public offers only through public media is not required to obtain registration as research analyst under RA Regulations”